Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26456430 | 0.88 | MCHR1 (0.35) | — | |
| SCHEMBL12448205 | 0.83 | PIK3CD (0.36) | PIK3CDACACB | |
| SCHEMBL21743295 | 0.79 | PIK3CD (0.34) | PIK3CDACACB | |
| SCHEMBL3383772 | 0.79 | PIK3CD (0.34) | PIK3CDACACB | |
| SCHEMBL19879610 | 0.78 | SLC1A3 (0.42) | — | |
| SCHEMBL24914243 | 0.77 | — | — | |
| SCHEMBL24087971 | 0.75 | TDP1 (0.40) | — | |
| SCHEMBL2257790 | 0.72 | IRAK4 (0.38) | PIK3CDACACB | |
| SCHEMBL18714401 | 0.72 | PIK3CD (0.30) | PIK3CD | |
| SCHEMBL19557920 | 0.71 | PIK3CD (0.38) | PIK3CD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230019236-A1 | PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF | CALICO LIFE SCIENCES LLC (US) | 2023-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230019236-A1 | PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF | PTPN1, PTPN2, PTPN18 | PIK3CD 316/4885ACACB 946/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.